Therapeutic Plasma Exchange Market
完整報告名稱與涵蓋範圍
Therapeutic Plasma Exchange Market Size, Share & Trends Analysis Report By Product & Technologies (Product (Consumables & Devices) And Technology (Centrifugation & Membrane Separation)), By Indication, By End-Users, Region And Segment Forecasts, 2025-2034
報告摘要
The global Therapeutic Plasma Exchange Market is poised to develop at a compound annual growth rate of 5.5% throughout the 2025–2034 forecast period.
Therapeutic Plasma Exchange encompasses a biological procedure that removes large-molecular-weight substances such as harmful antibodies from the plasma. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Growth is supported by a convergence of factors: rising awareness among end users, continuous product innovation, and the growing emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, supported by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Therapeutic Plasma Exchange Market Snapshot
Chapter 4. Global Therapeutic Plasma Exchange Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Penetration & Growth Prospect Mapping
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Products & Technology Advancement in Ambulatory Mammography
Chapter 5. Market Segmentation 1: Products & Technology Estimates & Trend Analysis
5.1. Products & Technology & Market Share, 2024 & 2034
5.2. Market Size (Value) & Forecasts and Trend Analyses, 2021 to 2034 for the following Products & Technology:
5.2.1. Product
Consumables
Devices
5.2.2. Technology
Centrifugation
Membrane Separation
Chapter 6. Market Segmentation 1: Indications & Trend Analysis
6.1. Indications & Market Share, 2024 & 2034
6.2. Market Size (Value)& Forecasts and Trend Analyses, 2021 to 2034 for the following Indications:
6.2.1. Neurological Disorders
Guillain–Barré syndrome
Chronic inflammatory demyelinating polyneuropathy
Myasthenia gravis
Multiple sclerosis
PANDASa
6.2.2. Hematology Disorders
Thrombotic thrombocytopenic purpura
Atypical haemolytic uraemic syndrome
Hyperviscosity syndromes
Severe/symptomatic cryoglobulinaemia
6.2.3. Renal Disorders
Goodpasture's syndrome
Wegener's glomerulonephritis
Antibody-mediated renal transplant rejection
6.2.4. Metabolic Disorders
Familial hypercholesterolaemia (homozygous)
6.2.5. Other Indications
Chapter 7. Market Segmentation 1: End-Users & Trend Analysis
7.1. End-Users & Market Share, 2024 & 2034
7.2. Market Size (Value)& Forecasts and Trend Analyses, 2021 to 2034 for the following End-Users
7.2.1. Blood Collection Centres & Blood Component Providers
7.2.2. Hospitals & Transfusion Centres
7.2.3. Other End Users
Chapter 8. Therapeutic Plasma Exchange Market Segmentation 3: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts Products & Technology, 2021-2034
8.1.2. North America Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts by Indications, 2021-2034
8.1.3. North America Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts End-Users, 2021-2034
8.1.4. North America Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe Therapeutic Plasma Exchange Market revenue (US$ Million) Products & Technology, 2021-2034
8.2.2. Europe Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts by Indications, 2021-2034
8.2.3. Europe Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts End-Users, 2021-2034
8.2.4. Europe Therapeutic Plasma Exchange Market revenue (US$ Million) by country, 2021-2034
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Therapeutic Plasma Exchange Market revenue (US$ Million) Products & Technology, 2021-2034
8.3.2. Asia Pacific Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts by Indications, 2021-2034
8.3.3. Asia Pacific Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts End-Users, 2021-2034
8.3.4. Asia Pacific Therapeutic Plasma Exchange Market revenue (US$ Million) by country, 2021-2034
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Therapeutic Plasma Exchange Market revenue (US$ Million) Products & Technology, 2021-2034
8.4.2. Latin America Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts by Indications, 2021-2034
8.4.3. Latin America Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts End-Users, 2021-2034
8.4.4. Latin America Therapeutic Plasma Exchange Market revenue (US$ Million) by country, 2021-2034
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. MEA
8.5.1. MEA Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts Products & Technology, 2021-2034
8.5.2. MEA Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts by Indications, 2021-2034
8.5.3. MEA Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts End-Users, 2021-2034
8.5.4. MEA revenue Therapeutic Plasma Exchange Market revenue (US$ Million) by country, (US$ Million) 2021-2034
8.5.4.1. South Africa
8.5.4.2. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. TERUMO BCT, INC.
9.2.2. FRESENIUS SE & CO. KGAA
9.2.3. HAEMONETICS CORPORATION
9.2.4. BAXTER INTERNATIONAL INC.
9.2.5. ASAHI KASEI MEDICAL CO. LTD.
9.2.6. BRAUN MELSUNGEN AG
9.2.7. CERUS CORPORATION
9.2.8. KANEKA CORPORATION
9.2.9. KAWASUMI LABORATORIES, INC.
9.2.10. NIKKISO CO., LTD.
9.2.11. MILTENYI BIOTEC
9.2.12. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們